Permanent changes in gene expression result from certain forms of antifungal resistance. In this study, we asked whether any changes in gene expression are required for the evolution of a drug-resistant phenotype in populations. We examined the changes in gene expression resulting from the evolution of resistance in experimental populations of the yeast Saccharomyces cerevisiae with two antifungal drugs, fluconazole (FLC) in a previous study and amphotericin B (AmB) in this study, in which five populations were subjected to increasing concentrations of AmB, from 0.25 to 128 g/ml in twofold increments. Six genes, YGR035C, YOR1, ICT1, GRE2, PDR16, and YPLO88W, were consistently overexpressed with resistance to AmB reported here and with resistance to FLC involving a mechanism of increased efflux reported previously. We then asked if the deletion of these genes impaired the ability of populations to evolve resistance to FLC over 108 generations of asexual reproduction in 32 and 128 g/ml FLC, the same conditions under which FLC-resistant types evolved originally. For each of three deletion strains, YOR1, ICT1, and PDR16 strains, extinctions occurred in one of two replicate populations growing in 128 g/ml FLC. Each of these three deletion strains was mixed 1:1 with a marked version of the wild type to measure the relative ability of the deletion strain to adapt over 108 generations. In these assays, only the PDR16 deletion strain consistently became extinct both at 32 and at 128 g/ml FLC. The deletion of PDR16 reduces the capacity of a population to evolve to resistance to FLC.Certain forms of antifungal drug resistance are accompanied by alterations in gene expression that persist even in the absence of the agent to which the resistance evolved (1,8,10,16,18,19). Are any of these changes in gene expression required for populations to acquire and support a drug-resistant phenotype? It is well established that the expression of HSP90 is a necessary precondition for the evolution and maintenance of certain forms of antifungal drug resistance in a phylogenetically broad array of fungi (6, 7). In this study, we examined the postconditions of resistance, specifically, the downstream gene expression changes resulting from the evolution of a resistant phenotype from a susceptible ancestor. We identified changes in gene expression common to resistance to two important antifungal drugs, fluconazole (FLC) and amphotericin B (AmB). We then asked if a deletion of these genes impaired the ability of populations to evolve resistance to FLC. The rationale was to include agents causing membrane stress by completely different mechanisms in order to search for genes whose expression had the broadest possible effect on the evolution of resistance.Most prominent among the resistance mechanisms causing widespread changes in gene expression include gain-of-function mutations in transcription factors, such as PDR1 and PDR3 in Saccharomyces cerevisiae, leading to increased levels of expression of efflux proteins, and a loss of function in o...